Amy Trombly
Tracked across 1 events · 6 articles · First seen Jun 30, 2026 · Last active Jun 30, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Amy Trombly, CEO of Sonoma Pharmaceuticals, commented on the expanded FDA clearance, highlighting its importance for the company's Microcyn technology platform and commercial partners.
Jun 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Amy Trombly live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard